Literature DB >> 15896466

Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness.

Sabine Krueger1, Thomas Kalinski, Hella Wolf, Udo Kellner, Albert Roessner.   

Abstract

To elucidate the importance of the tumor/host interaction in malignant tumors, we investigated the colon carcinoma cell line HT-29 in coculture with monocytic cells (THP-1) and fibroblasts (175BR) for cathepsin B expression and activity. The tumor cells were grown in monolayer cultures or as multicellular tumor spheroids. After coculture, the three cell types were separated by labeled magnetic beads for cathepsin B mRNA and protein analysis. The invasive potential was studied in in vitro invasion assays. The expression level of cathepsin B was found to be 10-fold increased in three dimensional spheroids of HT-29 compared to HT-29 monolayers. The coculture of HT-29 with THP-1 cells and/or human fibroblasts led to a considerable increase in cathepsin B mRNA expression in both tumor and tumor-associated cells. The invasive potential of the tumor cells was 5 times increased by adding monocytic cells to the assay system. This is dependent on the functional activity of cathepsin B as shown by specific siRNA's and seems to be regulated by activation of ERK1/2 and p38 signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15896466     DOI: 10.1016/j.canlet.2004.09.050

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.

Authors:  Claudia D Andl; Kelsey M McCowan; Gillian L Allison; Anil K Rustgi
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

2.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

3.  RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Daniel Spomar; Christopher S Gondi; William C Olivero; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

4.  Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B.

Authors:  Wen-Jie Jiao; Jing Xu; Hao Pan; Tian-You Wang; Yi Shen
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

Review 5.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 6.  Liquid-based three-dimensional tumor models for cancer research and drug discovery.

Authors:  Stephanie L Ham; Ramila Joshi; Pradip S Thakuri; Hossein Tavana
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-11

Review 7.  Co-culturing multicellular tumor models: Modeling the tumor microenvironment and analysis techniques.

Authors:  Ariana E Shannon; Claire E Boos; Amanda B Hummon
Journal:  Proteomics       Date:  2021-02-26       Impact factor: 3.984

8.  Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy.

Authors:  Peiman Habibollahi; Jose-Luiz Figueiredo; Pedram Heidari; Austin M Dulak; Yu Imamura; Adam J Bass; Shuji Ogino; Andrew T Chan; Umar Mahmood
Journal:  Theranostics       Date:  2012-02-16       Impact factor: 11.556

9.  Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.

Authors:  Verena Brune; Enrico Tiacci; Ines Pfeil; Claudia Döring; Susan Eckerle; Carel J M van Noesel; Wolfram Klapper; Brunangelo Falini; Anja von Heydebreck; Dirk Metzler; Andreas Bräuninger; Martin-Leo Hansmann; Ralf Küppers
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

10.  Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Authors:  László Herszényi; Fabio Farinati; Romilda Cardin; Gábor István; László D Molnár; István Hritz; Massimo De Paoli; Mario Plebani; Zsolt Tulassay
Journal:  BMC Cancer       Date:  2008-07-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.